GL1X · GenesisL1 explorer

Research workbench

The crystal structure of di-zn dihydropyrimidinase in complex with ncbi

Analyse The crystal structure of di-zn dihydropyrimidinase in complex with ncbi in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4LCQ
Type
protein
Length
485 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydropyrimidinase
Ligands
URQ, ZN
Pockets
2 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydropyrimidinaseprotein48536% helix, 23% strand—

Ligands and binding sites

  • URQ · (2S)-3-(carbamoylamino)-2-methylpropanoic acid · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11470.500.7918empty
2810.370.7619empty

Modifications

Observed in the structure: 1 modified (carboxylation).

Compared structures

  • 4LCQ · The crystal structure of di-Zn dihydropyrimidinase in complex with NCBI · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.